Advertisement
Screener

MARINUS PHARMACEUTICALS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

MARINUS PHARMACEUTICALS, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest

MARINUS PHARMACEUTICALS, INC. reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$98.72 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-12.

Financial Statements › Income Statement › Net Income

us-gaap:ProfitLoss · last filed 2024-11-12

  • MARINUS PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-09-30 was -$24.23M.
  • MARINUS PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-06-30 was -$35.83M.
  • MARINUS PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2024-03-31 was -$38.67M.
  • MARINUS PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2023-12-31 was -$41.77M.
  • MARINUS PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2023 was -$141.41M.
  • MARINUS PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2022 was -$19.82M.
  • MARINUS PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2021 was -$98.78M.
  • MARINUS PHARMACEUTICALS, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2020 was -$67.47M.
Period endNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 monthNet Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month
2024-09-30-$24.23M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$60.05M
derived: sum of 2 quarters · filed 2024-11-12
-$98.72M
10-Q · filed 2024-11-12
-$140.49M
derived: sum of 4 quarters · filed 2024-11-12
2024-06-30-$35.83M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$74.50M
10-Q · filed 2024-08-13
-$116.27M
derived: sum of 3 quarters · filed 2024-08-13
-$149.24M
derived: sum of 4 quarters · filed 2024-11-12
2024-03-31-$38.67M
10-Q · filed 2024-05-08
-$80.44M
derived: sum of 2 quarters · filed 2024-05-08
-$113.41M
derived: sum of 3 quarters · filed 2024-11-12
-$145.34M
derived: sum of 4 quarters · filed 2024-11-12
2023-12-31-$41.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
-$74.74M
derived: sum of 2 quarters · filed 2024-11-12
-$106.67M
derived: sum of 3 quarters · filed 2024-11-12
-$141.41M
10-K · filed 2024-03-05
2023-09-30-$32.97M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$64.91M
derived: sum of 2 quarters · filed 2024-11-12
-$99.64M
10-Q · filed 2024-11-12
-$133.95M
derived: sum of 4 quarters · filed 2024-11-12
2023-06-30-$31.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13
-$66.66M
10-Q · filed 2024-08-13
-$100.98M
derived: sum of 3 quarters · filed 2024-08-13
-$27.69M
derived: sum of 4 quarters · filed 2024-08-13
2023-03-31-$34.73M
10-Q · filed 2024-05-08
-$69.04M
derived: sum of 2 quarters · filed 2024-05-08
$4.25M
derived: sum of 3 quarters · filed 2024-05-08
-$35.19M
derived: sum of 4 quarters · filed 2024-05-08
2022-12-31-$34.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05
$38.98M
derived: sum of 2 quarters · filed 2024-03-05
-$455.00K
derived: sum of 3 quarters · filed 2024-03-05
-$19.82M
10-K · filed 2024-03-05
2022-09-30$73.29M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07
$33.86M
derived: sum of 2 quarters · filed 2023-11-07
$14.50M
10-Q · filed 2023-11-07
-$13.81M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30-$39.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$58.79M
10-Q · filed 2023-08-10
-$87.10M
derived: sum of 3 quarters · filed 2023-08-10
-$106.61M
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$19.36M
10-Q · filed 2023-05-11
-$47.67M
derived: sum of 2 quarters · filed 2023-05-11
-$67.17M
derived: sum of 3 quarters · filed 2023-05-11
-$91.00M
derived: sum of 4 quarters · filed 2023-05-11
2021-12-31-$28.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09
-$47.81M
derived: sum of 2 quarters · filed 2023-03-09
-$71.64M
derived: sum of 3 quarters · filed 2023-03-09
-$98.78M
10-K · filed 2023-03-09
2021-09-30-$19.51M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07
-$43.33M
derived: sum of 2 quarters · filed 2022-11-07
-$70.47M
10-Q · filed 2022-11-07
-$87.94M
derived: sum of 4 quarters · filed 2022-11-07
2021-06-30-$23.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
-$50.96M
10-Q · filed 2022-08-11
-$68.43M
derived: sum of 3 quarters · filed 2022-08-11
-$84.09M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31-$27.14M
10-Q · filed 2022-05-12
-$44.61M
derived: sum of 2 quarters · filed 2022-05-12
-$60.27M
derived: sum of 3 quarters · filed 2022-05-12
-$75.94M
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31-$17.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24
-$33.13M
derived: sum of 2 quarters · filed 2022-03-24
-$48.80M
derived: sum of 3 quarters · filed 2022-03-24
-$67.47M
10-K · filed 2022-03-24
2020-09-30-$15.66M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09
-$31.33M
derived: sum of 2 quarters · filed 2021-11-09
-$50.01M
10-Q · filed 2021-11-09
-$65.42M
derived: sum of 4 quarters · filed 2021-11-09
2020-06-30-$15.68M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10
-$34.35M
10-Q · filed 2021-08-10
-$49.76M
derived: sum of 3 quarters · filed 2021-08-10
-$63.56M
derived: sum of 4 quarters · filed 2021-08-10
2020-03-31-$18.67M
10-Q · filed 2021-05-17
-$34.08M
derived: sum of 2 quarters · filed 2021-05-17
-$47.89M
derived: sum of 3 quarters · filed 2021-05-17
-$60.31M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31-$15.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09
-$29.21M
derived: sum of 2 quarters · filed 2021-03-09
-$41.64M
derived: sum of 3 quarters · filed 2021-03-09
-$54.12M
10-K · filed 2021-03-09
2019-09-30-$13.81M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09
-$26.23M
derived: sum of 2 quarters · filed 2020-11-09
-$38.71M
10-Q · filed 2020-11-09
-$48.82M
derived: sum of 4 quarters · filed 2020-11-09
2019-06-30-$12.42M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06
-$24.91M
10-Q · filed 2020-08-06
-$35.02M
derived: sum of 3 quarters · filed 2020-08-06
-$46.13M
derived: sum of 4 quarters · filed 2020-08-06
2019-03-31-$12.48M
10-Q · filed 2020-05-04
-$22.59M
derived: sum of 2 quarters · filed 2020-05-04
-$33.70M
derived: sum of 3 quarters · filed 2020-05-04
-$43.21M
derived: sum of 4 quarters · filed 2020-05-04
2018-12-31-$10.11M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16
-$21.22M
derived: sum of 2 quarters · filed 2020-03-16
-$30.73M
derived: sum of 3 quarters · filed 2020-03-16
-$36.73M
10-K · filed 2020-03-16
2018-09-30-$11.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$20.61M
derived: sum of 2 quarters · filed 2019-11-06
-$26.61M
10-Q · filed 2019-11-06
-$31.35M
derived: sum of 4 quarters · filed 2019-11-06
2018-06-30-$9.51M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08
-$15.50M
10-Q · filed 2019-08-08
-$20.24M
derived: sum of 3 quarters · filed 2019-08-08
-$24.41M
derived: sum of 4 quarters · filed 2019-08-08
2018-03-31-$6.00M
10-Q · filed 2019-05-01
-$10.74M
derived: sum of 2 quarters · filed 2019-05-01
-$14.91M
derived: sum of 3 quarters · filed 2019-05-01
-$19.46M
derived: sum of 4 quarters · filed 2019-05-01
2017-12-31-$4.74M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
-$8.91M
derived: sum of 2 quarters · filed 2019-03-12
-$13.46M
derived: sum of 3 quarters · filed 2019-03-12
-$18.90M
10-K · filed 2019-03-12
2017-09-30-$4.17M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29
-$8.72M
derived: sum of 2 quarters · filed 2018-10-29
-$14.16M
10-Q · filed 2018-10-29
-$20.18M
derived: sum of 4 quarters · filed 2019-03-12
2017-06-30-$4.55M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03
-$9.99M
10-Q · filed 2018-08-03
-$16.00M
derived: sum of 3 quarters · filed 2019-03-12
-$22.47M
derived: sum of 4 quarters · filed 2019-03-12
2017-03-31-$5.44M
10-Q · filed 2018-05-02
-$11.45M
derived: sum of 2 quarters · filed 2019-03-12
-$17.92M
derived: sum of 3 quarters · filed 2019-03-12
2016-12-31-$6.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12
-$12.48M
derived: sum of 2 quarters · filed 2019-03-12
-$28.64M
10-K · filed 2019-03-12
2016-09-30-$6.46M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31
-$22.63M
10-Q · filed 2017-10-31
2016-06-30-$16.16M
10-Q · filed 2017-08-01
2015-12-31-$24.85M
10-K · filed 2018-03-07